Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit - PubMed (original) (raw)
Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit
P Yeh et al. J Virol. 1996 Jan.
Abstract
Transgene expression after the administration of recombinant adenovirus with E1 deleted is constantly transient. It is admitted that E1A-substituting activities of cellular or viral origin allow viral antigen synthesis and trigger cytotoxic lymphocyte-mediated clearance of the recipient cells. Our approach to solving this problem relies on the additional deletion of the E4 region from the vector backbone as this region upregulates viral gene expression at both transcriptional and posttranscriptional levels. As a prerequisite to the construction of E1 E4 doubly defective adenoviruses, we investigated the possibility of transcomplementing both functions within a single cell. In particular, the distal ORF6+ORF7 segment from the E4 locus of adenovirus type 5 was cloned under the control of the dexamethasone-inducible mouse mammary tumor virus long terminal repeat. Following transfection into 293 cells, clone IGRP2 was retained and characterized as it can rescue the growth defect of all E1+ E4- adenoviral deletants tested. DNA and RNA analysis experiments verified that the mouse mammary tumor virus promoter drives the expression of the ORF6+ORF7 unit and permits its bona fide alternative splicing, generating ORF6/7 mRNA in addition to the ORF6-expressing primary transcript. Importantly, IGRP2 cells sustain cell confluence for a period longer than that of 293 parental cells and allow the plaque purification of E1- or E4- defective viruses. The dual expression of E1 and E4 regulatory genes within IGRP2 cells is demonstrated by the construction, plaque purification, and helper-free propagation of recombinant lacZ-encoding doubly defective adenoviruses harboring different E4 deletions. In addition, the emergence, if any, of replicative particles during viral propagation in this novel packaging cell line will be drastically impaired as only a limited segment of E4 has been integrated.
Similar articles
- Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants.
Krougliak V, Graham FL. Krougliak V, et al. Hum Gene Ther. 1995 Dec;6(12):1575-86. doi: 10.1089/hum.1995.6.12-1575. Hum Gene Ther. 1995. PMID: 8664382 - A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4.
Brough DE, Lizonova A, Hsu C, Kulesa VA, Kovesdi I. Brough DE, et al. J Virol. 1996 Sep;70(9):6497-501. doi: 10.1128/JVI.70.9.6497-6501.1996. J Virol. 1996. PMID: 8709289 Free PMC article. - Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3.
Gorziglia MI, Lapcevich C, Roy S, Kang Q, Kadan M, Wu V, Pechan P, Kaleko M. Gorziglia MI, et al. J Virol. 1999 Jul;73(7):6048-55. doi: 10.1128/JVI.73.7.6048-6055.1999. J Virol. 1999. PMID: 10364357 Free PMC article. - Cell transformation by the adenovirus oncogenes E1 and E4.
Ip WH, Dobner T. Ip WH, et al. FEBS Lett. 2020 Jun;594(12):1848-1860. doi: 10.1002/1873-3468.13717. Epub 2019 Dec 20. FEBS Lett. 2020. PMID: 31821536 Review. - Cell transformation by human adenoviruses.
Endter C, Dobner T. Endter C, et al. Curr Top Microbiol Immunol. 2004;273:163-214. doi: 10.1007/978-3-662-05599-1_6. Curr Top Microbiol Immunol. 2004. PMID: 14674602 Review.
Cited by
- Construction and application of adenoviral vectors.
Zhang H, Wang H, An Y, Chen Z. Zhang H, et al. Mol Ther Nucleic Acids. 2023 Sep 9;34:102027. doi: 10.1016/j.omtn.2023.09.004. eCollection 2023 Dec 12. Mol Ther Nucleic Acids. 2023. PMID: 37808925 Free PMC article. Review. - Adenoviral vector-based strategies against infectious disease and cancer.
Zhang C, Zhou D. Zhang C, et al. Hum Vaccin Immunother. 2016 Aug 2;12(8):2064-2074. doi: 10.1080/21645515.2016.1165908. Epub 2016 Apr 22. Hum Vaccin Immunother. 2016. PMID: 27105067 Free PMC article. Review. - Adenoviral producer cells.
Kovesdi I, Hedley SJ. Kovesdi I, et al. Viruses. 2010 Aug;2(8):1681-1703. doi: 10.3390/v2081681. Epub 2010 Aug 16. Viruses. 2010. PMID: 21994701 Free PMC article. - New insights on adenovirus as vaccine vectors.
Lasaro MO, Ertl HC. Lasaro MO, et al. Mol Ther. 2009 Aug;17(8):1333-9. doi: 10.1038/mt.2009.130. Epub 2009 Jun 9. Mol Ther. 2009. PMID: 19513019 Free PMC article. Review. - Adenoviruses as vaccine vectors.
Tatsis N, Ertl HC. Tatsis N, et al. Mol Ther. 2004 Oct;10(4):616-29. doi: 10.1016/j.ymthe.2004.07.013. Mol Ther. 2004. PMID: 15451446 Free PMC article. Review.
References
- Virology. 1973 Apr;52(2):456-67 - PubMed
- Virology. 1993 May;194(1):50-8 - PubMed
- J Virol. 1979 Feb;29(2):458-65 - PubMed
- Proc Natl Acad Sci U S A. 1980 Apr;77(4):1893-7 - PubMed
- Virology. 1981 Oct 15;114(1):196-209 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials